Digital health service, Numan, secures a fundraising of $60 million
In a significant move for the digital health sector, UK-based Numan, a pioneering digital health provider, has secured a $60 million funding round. This investment will propel the company's long-term vision of redefining preventive healthcare and expanding its reach.
The funding, led by Big Pi Ventures, will be utilised to scale the platform's infrastructure, advance AI capabilities, and broaden marketing efforts, enabling Numan to serve a growing patient base more effectively. The investment also marks an extension of Numan's Series B round, with Endeavor Catalyst and existing investors White Star Capital and Novator Partners also participating.
Numan's vision is to transform the way people experience and think about healthcare, bridging the gap between prevention and cure. The company's platform unites diagnostics, medication, expert care, and behavioural change into one seamless patient journey, with a focus on personalised, integrated care.
The funding will be instrumental in realising this vision, particularly in underserved areas such as obesity and testosterone deficiency, while expanding into stigmatised health conditions. Numan is also planning to enter the women’s health sector, filling critical gaps in the market and enhancing screening and preventive care programs.
Numan's expansion will not be limited to the UK. The company aims to leverage the investment to support its international growth, targeting new markets with fragmented care systems where access to preventive services is limited.
In addition to its direct services, Numan is developing B2B partnerships with employers and insurance providers to promote preventive healthcare programs that improve workforce health and reduce long-term costs.
Numan's mission is not just about providing healthcare; it's about preventing illnesses before they occur. The company is building a comprehensive, preventative health platform using proprietary technology and data to offer personalised, integrated care focusing on diagnostics, medications, behavioural coaching, and expert guidance.
Big Pi Ventures' Partner, Nick Kalliagkopoulos, expressed his excitement about Numan's potential to tackle healthcare challenges and deliver better health outcomes. HSBC Innovation Banking, proud to support Numan's growth, provided access to $27 million in growth capital, further bolstering the company's expansion plans.
With this funding, Numan is poised to redefine proactive healthcare in the UK and beyond, accelerating growth, expanding internationally, and unlocking access to new areas of care. The company is on track to achieve 150% growth in 2025, with reported revenue of $90 million in 2024 and plans to maintain profitability while expanding its patient base.
- The funding secured by Numan, a digital health provider, will be used to scale its technology-driven platform, improving AI capabilities, broadening marketing efforts, and advancing into new markets, such as women's health, to enhance preventive care programs and bridge gaps in health-and-wellness sectors.
- The venture capital investment in Numan signifies a significant step in the health tech industry, as the company aims to expand globally and redefine proactive healthcare, leveraging science and technology to offer personalised, integrated care solutions focused on diagnostics, medications, behavioural coaching, and expert guidance.
